Risk of lymphoma subtypes after solid organ transplantation in the United States

British Journal of Cancer

Volumn 109, Issue 1, 2013, Pages 280-288

  Clarke, C A ^a,b   Morton, L M ^c   Lynch, C ^d   Pfeiffer, R M ^c   Hall, E C ^c   Gibson, T M ^c   Weisenburger, D D ^e   Martinez Maza O ^f   Hussain, S K ^f   Yang, J ^a   Chang, E T ^b   Engels, E A ^c  

^a CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BURKITT LYMPHOMA; CANCER REGISTRY; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEPATOSPLENIC T CELL LYMPHOMA; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MYCOSIS FUNGOIDES; NK T CELL LYMPHOMA; NONHODGKIN LYMPHOMA; ORGAN TRANSPLANTATION; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; SEZARY SYNDROME; STANDARDIZED INCIDENCE RATIO; T CELL LYMPHOMA; UNITED STATES; WALDENSTROEM MACROGLOBULINEMIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; LYMPHOMA; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; REGISTRIES; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

EID: 84880285484     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.294     Document Type: Article

References (44)

1. Andreone P, Gramenzi A, Lorenzini S, Biselli M, Cursaro C, Pileri S, Bernardi M (2003) Posttransplantation lymphoproliferative disorders. Arch Intern Med 163: 1997-2004.
2. Baccarani U, Piselli P, Serraino D, Adani GL, Lorenzin D, Gambato M, Buda A, Zanus G, Vitale A, De Paoli A, Cimaglia C, Bresadola V, Toniutto P, Risaliti A, Cillo U, Bresadola F, Burra P (2009) Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries. Dig Liver Dis 42: 55-60.
3. Bierman PJ, Vose JM, Langnas AN, Rifkin RM, Hauke RJ, Smir BN, Greiner TC (1996) Hodgkin's disease following solid organ transplantation. Ann Oncol 7: 265-270.
4. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA (2007) AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 99: 962-972.
5. Busnach G, Piselli P, Arbustini E, Baccarani U, Burra P, Carrieri MP, Citterio F, De Juli E, Bellelli S, Pradier C, Rezza G, Serraino D (2006) Immunosuppression and cancer: a comparison of risks in recipients of organ transplants and in HIV-positive individuals. Transplant Proc 38: 3533-3535.
6. Bustami RT, Ojo AO, Wolfe RA, Merion RM, Bennett WM, McDiarmid SV, Leichtman AB, Held PJ, Port FK (2004) Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant 4: 87-93.
7. Caillard S, Lelong C, Pessione F, Moulin B (2006) Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry. Am J Transplant 6: 2735-2742.
8. Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF (2009) HIVassociated lymphomas and gamma-herpesviruses. Blood 113: 1213-1224.
9. Clarke CA, Glaser SL, Dorfman RF, Bracci PM, Eberle E, Holly EA (2004) Expert review of non-Hodgkin's lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications. Cancer Epidemiol Biomarkers Prev 13: 138-143.
10. Clarke CA, Undurraga DM, Harasty PJ, Glaser SL, Morton LM, Holly EA (2006) Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol Biomarkers Prev 15: 630-638.
11. de Sanjose S, Benavente Y, Vajdic CM, Engels EA, Morton LM, Bracci PM, Spinelli JJ, Zheng T, Zhang Y, Franceschi S, Talamini R, Holly EA, Grulich AE, Cerhan JR, Hartge P, Cozen W, Boffetta P, Brennan P, Maynadie M, Cocco P, Bosch R, Foretova L, Staines A, Becker N, Nieters A (2008) Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol 6: 451-458.
12. Deepak P, Sifuentes H, Sherid M, Stobaugh D, Sadozai Y, Ehrenpreis ED (2013) T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-alpha) inhibitors: results of the REFURBISH study. Am J Gastroenterol 108: 99-105.
13. Dharnidharka VR, Lamb KE, Gregg JA, Meier-Kriesche HU (2012) Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States. Am J Transplant 12: 976-983.
14. Engels EA (2007) Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16: 401-404.
15. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, McNeel TS, Goedert JJ (2008) Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123: 187-194.
16. Engels EA, Pfeiffer RM, Fraumeni Jr. JF, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M (2011) Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306: 1891-1901.
17. Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, Biggar RJ (2006) Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 20: 1645-1654.
18. Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA (2007) Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 297: 2010-2017.
19. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM (2007) Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370: 59-67.
20. Hellgren K, Iliadou A, Rosenquist R, Feltelius N, Backlin C, Enblad G, Askling J, Baecklund E (2010) Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study. Ann Rheum Dis 69: 654-659.
21. Jagadeesh D, Woda BA, Draper J, Evens AM (2012) Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. Curr Treat Options Oncol 13: 122-136.
22. Jenson HB (2011) Epstein-Barr virus. Pediatr Rev 32: 375-383, quiz 384.
23. Jiang Y, Villeneuve PJ, Fenton SS, Schaubel DE, Lilly L, Mao Y (2008) Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study. Liver Transpl 14: 1588-1597.
24. Jiang Y, Villeneuve PJ, Wielgosz A, Schaubel DE, Fenton SS, Mao Y (2010) The incidence of cancer in a population-based cohort of Canadian heart transplant recipients. Am J Transplant 10: 637-645.
25. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C (2004) Cancer after kidney transplantation in the United States. Am J Transplant 4: 905-913.
26. Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW (2009) Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center. J Clin Oncol 27: 3354-3362.
27. LaCasce AS (2006) Post-transplant lymphoproliferative disorders. Oncologist 11: 674-680.
28. Mason M, Siegel CA (2013) Do inflammatory bowel disease therapies cause cancer? Inflamm Bowel Dis 19(6): 1306-1321.
29. Mbulaiteye SM, Biggar RJ, Goedert JJ, Engels EA (2003) Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 32: 527-533.
30. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107: 265-276.
31. Opelz G, Daniel V, Naujokat C, Dohler B (2009) Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non- Hodgkin lymphoma. Transplantation 88: 962-967.
32. Opelz G, Dohler B (2004) Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 4: 222-230.
33. Quinlan SC, Landgren O, Morton LM, Engels EA (2010) Hodgkin lymphoma among US solid organ transplant recipients. Transplantation 90: 1011-1015.
34. Quinlan SC, Morton LM, Pfeiffer RM, Anderson LA, Landgren O, Warren JL, Engels EA (2010) Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients. Cancer Epidemiol Biomarkers Prev 19: 1229-1237.
35. Quinlan SC, Pfeiffer RM, Morton LM, Engels EA (2011) Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol 86: 206-209.
36. Serraino D, Piselli P, Busnach G, Burra P, Citterio F, Arbustini E, Baccarani U, De Juli E, Pozzetto U, Bellelli S, Polesel J, Pradier C, Dal Maso L, Angeletti C, Carrieri MP, Rezza G, Franceschi S (2007) Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe. Eur J Cancer 43: 2117-2123.
37. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. France International Agency for Research on Cancer: Lyon.
38. Tsao L, Hsi ED (2007) The clinicopathologic spectrum of posttransplantation lymphoproliferative disorders. Arch Pathol Lab Med 131: 1209-1218.
39. Turner JJ, Morton LM, Linet MS, Clarke CA, Kadin ME, Vajdic CM, Monnereau A, Maynadie M, Chiu BC, Marcos-Gragera R, Costantini AS, Cerhan JR, Weisenburger DD (2010) InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO Classification (2008): update and future directions. Blood 116(20): e90-e98.
40. Vajdic CM, McDonald SP, McCredie MR, van Leeuwen MT, Stewart JH, Law M, Chapman JR, Webster AC, Kaldor JM, Grulich AE (2006) Cancer incidence before and after kidney transplantation. JAMA 296: 2823-2831.
41. Vajdic CM, van Leeuwen MT (2009) Cancer incidence and risk factors after solid organ transplantation. Int J Cancer 125: 1747-1754.
42. Vajdic CM, van Leeuwen MT, Turner JJ, McDonald AM, Webster AC, McDonald SP, Chapman JR, Kaldor JM, Grulich AE (2010) No excess risk of follicular lymphoma in kidney transplant and HIV-related immunodeficiency. Int J Cancer 127: 2732-2735.
43. van Leeuwen MT, Grulich AE, Webster AC, McCredie MR, Stewart JH, McDonald SP, Amin J, Kaldor JM, Chapman JR, Vajdic CM (2009) Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation. Blood 114: 630-637.
44. van Leeuwen MT, Vajdic CM, Middleton MG, McDonald AM, Law M, Kaldor JM, Grulich AE (2009) Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 23: 2183-2190.